0001209191-20-035039.txt : 20200608 0001209191-20-035039.hdr.sgml : 20200608 20200608173733 ACCESSION NUMBER: 0001209191-20-035039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200605 FILED AS OF DATE: 20200608 DATE AS OF CHANGE: 20200608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duncan Barbara Gayle CENTRAL INDEX KEY: 0001353128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38085 FILM NUMBER: 20950175 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES STREET CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ovid Therapeutics Inc. CENTRAL INDEX KEY: 0001636651 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465270895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-776-4381 MAIL ADDRESS: STREET 1: 1460 BROADWAY STREET 2: SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-05 0 0001636651 Ovid Therapeutics Inc. OVID 0001353128 Duncan Barbara Gayle C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036 1 0 0 0 Stock Option (Right to Buy) 5.29 2020-06-05 4 A 0 13250 0.00 A 2030-06-04 Common Stock 13250 13250 D The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date. /s/ Danielle Mann for Barbara G. Duncan by POA 2020-06-08